Safety of blood products derived from plasma pools: The positive impact of anti-HCV screening on the quality of such products

被引：5

作者：

Cardoso, MD ^{[1
]}

Koerner, K ^{[1
]}

Epple, S ^{[1
]}

Kubanek, B ^{[1
]}

机构：

[1] UNIV ULM,DEPT TRANSFUS MED,D-89081 ULM,GERMANY

来源：

VOX SANGUINIS | 1996年 / 71卷 / 03期

关键词：

D O I：

10.1046/j.1423-0410.1996.7130184.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：184 / 186

页数：3

共 7 条

[1] THE USE OF A RECOMBINANT IMMUNOBLOT ASSAY IN THE INTERPRETATION OF ANTI-HEPATITIS-C VIRUS REACTIVITY AMONG PROSPECTIVELY FOLLOWED PATIENTS, IMPLICATED DONORS, AND RANDOM DONORS [J].

ALTER, HJ ;

TEGTMEIER, GE ;

JETT, BW ;

QUAN, S ;

SHIH, JW ;

BAYER, WL ;

POLITO, A .

TRANSFUSION, 1991, 31 (08) :771-776

[2] THE EFFECT ON THE SAFETY OF INTRAVENOUS IMMUNOGLOBULIN OF TESTING PLASMA FOR ANTIBODY TO HEPATITIS-C [J].

BISWAS, RM ;

NEDJAR, S ;

WILSON, LT ;

MITCHELL, FD ;

SNOY, PJ ;

FINLAYSON, JS ;

TANKERSLEY, DL .

TRANSFUSION, 1994, 34 (02) :100-104

[3] PREVALENCE OF HCV-RNA-POSITIVE BLOOD-DONORS AND CORRELATION TO ELISA AND RIBA STATUS [J].

CARDOSO, MD ;

KOERNER, K ;

EPPLE, S ;

KUBANEK, B .

ANNALS OF HEMATOLOGY, 1993, 66 (03) :147-151

[4]

DAMEN M, IN PRESS J VIROL MET

[5] IMPROVED DETECTION OF HEPATITIS-C VIRUS-ANTIBODIES IN HIGH-RISK POPULATIONS [J].

MCHUTCHISON, JG ;

PERSON, JL ;

GOVINDARAJAN, S ;

VALINLUCK, B ;

GORE, T ;

LEE, SR ;

NELLES, M ;

POLITO, A ;

CHIEN, D ;

DINELLO, R ;

QUAN, S ;

KUO, G ;

REDEKER, AG .

HEPATOLOGY, 1992, 15 (01) :19-25

[6]

NUBLING CM, 1995, LANCET, V345, P1173

[7]

1994, MMWR-MORBID MORTAL W, V43, P505

← 1 →